Nancy Agrawal, based in United States, is currently a Executive Vice President, Preclinical Development at Atea Pharmaceuticals, Inc, bringing experience from previous roles at Merck. Nancy Agrawal holds a 1994 - 1996 PhD in Chemical Engineering @ University of Michigan. With a robust skill set that includes DMPK, Pharmacokinetics, Clinical Development, Pharmacodynamics, Drug Metabolism and more, Nancy Agrawal contributes valuable insights to the industry. Nancy Agrawal has 1 email on RocketReach.